SIGMAR1 and Stroke: The activation of Sig-1R may block the inflammatory response in rodent models of stroke and amyotrophic lateral sclerosis via decreasing the number of reactive astrocytes [13,14], and suppress amyloid-β-mediated hippocampal astrocyte and microglial proliferation [41].